Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

7 Oct 2022 16:28

RNS Number : 2322C
Maven Income & Growth VCT PLC
07 October 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Joint Announcement by Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC

Offers for Subscription

7 October 2022

 

The Board of Directors of Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC (together the "Companies" and each a "Company") are pleased to announce that they have published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares of 10p each in each of the Companies to raise, in aggregate, up to £40 million, including over-allotment facilities of up to, in aggregate, £10 million (before issue costs) (the "Offers" and each an "Offer").

The Companies have also published a joint Circular (the "Circular") seeking the approval of their respective shareholders for the allotment and disapplication authorities in connection with the Offers and each Company giving notice of a General Meeting to be held on 9 November 2022 (the "General Meeting").

The Offers will open on 7 October 2022 and the deadline for receipt of applications is 12.00 noon on 4 April 2023 in relation to the tax year 2022/23 and 12.00 noon on 26 May 2023 in relation to the tax year 2023/24. The Offers will close on 31 May 2023 unless the relevant Offer is fully subscribed by an earlier date or previously extended by the relevant Board to no later than 6 October 2023

Each Offer is conditional on the passing of certain resolutions at the relevant General Meeting.

Pursuant to individual offer agreements dated 7 October 2022 relating to each Offer between, among others, each relevant Company and Maven Capital Partners LLP ("Maven"), Maven, as the administrator of each Offer, will receive an offer administration fee of 2.5% of the application amount in relation to each accepted application, with reductions to the offer administration fee applying for applications that benefit from an Early Investment Incentive discount, or as may otherwise be waived by Maven. Maven, as the investment manager of each Company, is a related party of each Company under the Listing Rules, and the payment of such a fee by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

To obtain a copy of the Securities Note, private investors and financial advisers should call Maven on 0141 306 7400. A downloadable version of the Securities Note will shortly be available from the Maven website: www.mavencp.com/vctoffer.

Copies of the Prospectus and Circular are available, free of charge, from Maven at Kintyre House, 205 West George Street, Glasgow G2 2LW.

Copies of the Prospectus have been submitted to the National Storage Mechanism and will shortly be available for viewing online at the following website address: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Any enquiries in respect of the Offers should be directed to:

Maven Capital Partners UK LLPTelephone: 0141 306 7400

E-mail: enquiries@mavencp.com

The information contained within this announcement is deemed by the Companies to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

Notes

 

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIZZMGGKNVGZZM
Date   Source Headline
25th Mar 20194:09 pmRNSStatement re Offer for Subscription
13th Mar 201912:12 pmRNSTransaction in Own Shares
7th Mar 20195:50 pmRNSIssue of Equity
4th Mar 201912:40 pmRNSNet Asset Value(s)
28th Feb 20195:42 pmRNSAnnual Financial Report
20th Feb 201912:30 pmRNSStatement re Offer for Subscription
15th Jan 20194:17 pmRNSTransaction in Own Shares
11th Jan 20193:50 pmRNSHolding(s) in Company
21st Dec 20181:00 pmRNSDirector/PDMR Shareholding
21st Dec 201810:39 amRNSIssue of Equity
18th Dec 20184:17 pmRNSNet Asset Value
5th Nov 20184:52 pmRNSTransaction in Own Shares
2nd Nov 201811:38 amRNSResult of General Meeting
10th Oct 20185:06 pmRNSTransaction in Own Shares
8th Oct 20184:48 pmRNSTransaction in Own Shares
5th Oct 20184:04 pmRNSTransaction in Own Shares
4th Oct 20183:03 pmRNSTransaction in Own Shares
3rd Oct 20187:00 amRNSNet Asset Value(s)
26th Sep 20186:29 pmRNSStatement re Offer for Subscription
24th Jul 20184:58 pmRNSTransaction in Own Shares
20th Jul 20182:56 pmRNSHalf-year Report
18th Jul 20189:21 amRNSNet Asset Value(s)
18th Jul 20187:00 amRNSStatement re Offer for Subscription
2nd May 20184:59 pmRNSHolding(s) in Company
25th Apr 20184:39 pmRNSNet Asset Value(s)
24th Apr 20181:34 pmRNSResult of AGM
12th Mar 20187:15 amRNSHolding(s) in Company
12th Mar 20187:00 amRNSAnnual Financial Report
8th Mar 20183:30 pmRNSDividend Declaration
27th Feb 20184:02 pmRNSTransaction in Own Shares
13th Feb 20183:39 pmRNSTransaction in Own Shares
25th Jan 20185:01 pmRNSTransaction in Own Shares
23rd Jan 20185:23 pmRNSTransaction in Own Shares
17th Jan 20182:46 pmRNSNet Asset Value(s)
3rd Jan 20182:00 pmRNSForm 8.3 - Plant Impact PLC
30th Nov 20174:42 pmRNSTransaction in Own Shares
29th Nov 20174:40 pmRNSTransaction in Own Shares
25th Oct 20173:05 pmRNSDividend Declaration
29th Sep 20174:01 pmRNSNet Asset Value(s)
23rd Aug 20174:50 pmRNSTransaction in Own Shares
23rd Aug 20177:00 amRNSTransaction in Own Shares
22nd Aug 20177:00 amRNSHalf-year Report
10th Aug 20174:11 pmRNSNet Asset Value and Interim Dividend
31st May 20174:58 pmRNSTransaction in Own Shares
16th May 20173:57 pmRNSTransaction in Own Shares
11th May 20172:03 pmRNSTransaction in Own Shares
25th Apr 20172:14 pmRNSResult of AGM
25th Apr 20172:12 pmRNSNet Asset Value and Proposed Final Dividend
6th Mar 20176:12 pmRNSAnnual Financial Report
6th Mar 20176:04 pmRNSCorrective Statement re Proposed Final Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.